Article Versions Notes

Marin JJG, Macias RIR, Monte MJ, Herraez E, Peleteiro-Vigil A, Blas BSd, Sanchon-Sanchez P, Temprano AG, Espinosa-Escudero RA, Lozano E, et al. Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. Cancers. 2020; 12(9):2605. https://doi.org/10.3390/cancers12092605

Marin, Jose J.G., Rocio I.R. Macias, Maria J. Monte, Elisa Herraez, Ana Peleteiro-Vigil, Beatriz Sanchez de Blas, Paula Sanchon-Sanchez, Alvaro G. Temprano, Ricardo A. Espinosa-Escudero, Elisa Lozano, and et al. 2020. "Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment" Cancers 12, no. 9: 2605. https://doi.org/10.3390/cancers12092605

Marin, J. J. G., Macias, R. I. R., Monte, M. J., Herraez, E., Peleteiro-Vigil, A., Blas, B. S. d., Sanchon-Sanchez, P., Temprano, A. G., Espinosa-Escudero, R. A., Lozano, E., Briz, O., & Romero, M. R. (2020). Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. Cancers, 12(9), 2605. https://doi.org/10.3390/cancers12092605